These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 19331206)
1. Outpatient chemotherapy with S-1 for recurrent head and neck cancer. Yamashita T; Shinden S; Watabe T; Shiotani A Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206 [TBL] [Abstract][Full Text] [Related]
2. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy. Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053 [TBL] [Abstract][Full Text] [Related]
3. Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer. Maeda M; Yamashita T; Matsunobu T; Araki K; Tomifuji M; Shiotani A Anticancer Res; 2013 Aug; 33(8):3285-9. PubMed ID: 23898093 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer. Suzuki S; Ishikawa K J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075 [TBL] [Abstract][Full Text] [Related]
5. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)]. Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577 [TBL] [Abstract][Full Text] [Related]
6. [Results of chemotherapy in head and neck cancer patients with residual or recurrent tumors after initial treatment]. Katsuno M; Watanabe N; Sugio Y; Tachibana S; Tani Y; Sato N; Zusho H Gan To Kagaku Ryoho; 2010 Nov; 37(11):2109-13. PubMed ID: 21084809 [TBL] [Abstract][Full Text] [Related]
7. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Tsukuda M; Kida A; Fujii M; Kono N; Yoshihara T; Hasegawa Y; Sugita M; Br J Cancer; 2005 Oct; 93(8):884-9. PubMed ID: 16189518 [TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761 [TBL] [Abstract][Full Text] [Related]
9. [Late phase II study of S-1 in patients with advanced head and neck cancer]. Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B; Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer. Kodaira T; Fuwa N; Tachibana H; Hidano S Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599 [TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer. Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558 [TBL] [Abstract][Full Text] [Related]
13. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1. Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048 [TBL] [Abstract][Full Text] [Related]
14. Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. Guardiola E; Peyrade F; Chaigneau L; Cupissol D; Tchiknavorian X; Bompas E; Madroszyk A; Ronchin P; Schneider M; Bleuze JP; Blay JY; Pivot X Eur J Cancer; 2004 Sep; 40(14):2071-6. PubMed ID: 15341981 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Yoshida K; Ninomiya M; Takakura N; Hirabayashi N; Takiyama W; Sato Y; Todo S; Terashima M; Gotoh M; Sakamoto J; Nishiyama M Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3402-7. PubMed ID: 16740764 [TBL] [Abstract][Full Text] [Related]
16. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN). Baghi M; Hambek M; Wagenblast J; May A; Gstoettner W; Knecht R Anticancer Res; 2006; 26(1B):585-90. PubMed ID: 16739325 [TBL] [Abstract][Full Text] [Related]
17. [Results of treatment of far advanced and recurrent stomach cancer with TS-1]. Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer. Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365 [TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with S-1 for head and neck carcinoma]. Terao K; Saito K; Mori K; Murata K Gan To Kagaku Ryoho; 2008 Mar; 35(3):425-9. PubMed ID: 18347390 [TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]